World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
23678
World Ranking
14264
National Ranking
545

Ton Lisman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ton Lisman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 505 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ton Lisman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ton Lisman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ton Lisman is affiliated with the University Medical Center Groningen in the Netherlands. Their research focuses primarily on medicine, with significant contributions to hepatology, epidemiology, surgery, hematology, and internal medicine.

Lisman's work extensively covers topics related to liver disease and transplantation, liver disease diagnosis and treatment, organ transplantation techniques and outcomes, venous thromboembolism diagnosis and management, trauma, hemostasis, coagulopathy, resuscitation, COVID-19 clinical research studies, and neutrophil, myeloperoxidase, and oxidative mechanisms.

Frequently publishing in a range of respected venues, Lisman has contributed notably to:

  • Journal of Thrombosis and Haemostasis
  • Journal of Hepatology
  • Research and Practice in Thrombosis and Haemostasis
  • Seminars in Thrombosis and Hemostasis
  • Hepatology

Lisman has collaborated repeatedly with several researchers, including:

  • Jelle Adelmeijer
  • Fien A. von Meijenfeldt
  • William Bernal
  • Robert J. Porte
  • Vincent E. de Meijer

Among the recent scientific papers associated with Lisman's field of study, important publications include:

  • "Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases," 2020, Hepatology
  • "Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial," 2020, The Lancet
  • "EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis," 2022, Journal of Hepatology
  • "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report," 2020, Arteriosclerosis Thrombosis and Vascular Biology
  • "Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19," 2020, Arteriosclerosis Thrombosis and Vascular Biology

The body of Lisman's research underlines a sustained focus on liver diseases, coagulopathy, and transplantation medicine, often intersecting with advances in hematology and clinical outcomes related to COVID-19. Their contributions have impacted both clinical guidelines and foundational understanding within these fields.

Best Publications

  • Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences

    Ton Lisman;Robert J. Porte

  • Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

    Ton Lisman;Ton Lisman;Tamara N. Bongers;Jelle Adelmeijer;Harry L.A. Janssen

  • Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management

    Stephen H. Caldwell;Maureane Hoffman;Ton Lisman;B. Gail Macik

  • Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

    Mirjam E. Meltzer;Mirjam E. Meltzer;Ton Lisman;Ton Lisman;Philip G. de Groot;Joost C.M. Meijers

  • Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.

    Patrick G Northup;Juan Carlos Garcia-Pagan;Guadalupe Garcia-Tsao;Guadalupe Garcia-Tsao;Nicolas M Intagliata

  • Hemostasis and thrombosis in patients with liver disease: The ups and downs

    Ton Lisman;Stephen H. Caldwell;Andrew K. Burroughs;Patrick G. Northup

  • Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1

    Robert Jan Lebbink;Talitha Eshuis-de Ruiter;Jelle Adelmeijer;Arjan B. Brenkman

  • Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

    Ian Roberts;Haleema Shakur-Still;Adefemi Afolabi;Adegboyega Akere

  • Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis

    Ton Lisman;Frank W.G. Leebeek;Laurent O. Mosnier;Bonno N. Bouma

  • Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

    Ton Lisman;Philip G. de Groot;Joost C.M. Meijers;Frits R. Rosendaal

  • Haemostatic abnormalities in patients with liver disease

    Ton Lisman;Frank W.G. Leebeek;Philip G. de Groot

  • Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography

    R. Todd Stravitz;Ton Lisman;Velimir A. Luketic;Richard K. Sterling

  • Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers

    S. op den Dries;Negin Karimian;M. E. Sutton;A. C. Westerkamp

  • Lupus anticoagulants and the risk of a first episode of deep venous thrombosis

    P. G De Groot;B. Lutters;R. H. W. M. Derksen;T. Lisman

  • Platelet Transfusion During Liver Transplantation Is Associated with Increased Postoperative Mortality Due to Acute Lung Injury

    Ilona T. A. Pereboom;Marieke T. de Boer;Elizabeth B. Haagsma;Herman G. D. Hendriks

  • Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death

    van Rianne Rijn;Negin Karimian;A P M Matton;Laura Burlage

  • Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests

    Ton Lisman;Kamran Bakhtiari;Ilona T.A. Pereboom;Herman G.D. Hendriks

  • Criteria for Viability Assessment of Discarded Human Donor Livers during Ex-Vivo Normothermic Machine Perfusion.

    Michael E. Sutton;Sanna op den Dries;Negin Karimian;Pepijn D. Weeder

  • Hemostatic Alterations in Liver Disease: A Review on Pathophysiology, Clinical Consequences, and Treatment

    Ton Lisman;Frank W. G. Leebeek

  • An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome

    Greg C. G. Hugenholtz;Jelle Adelmeijer;Joost C. M. Meijers;Robert J. Porte

Frequent Co-Authors

Robert J. Porte
Robert J. Porte University Medical Center Groningen
Philip G. de Groot
Philip G. de Groot Utrecht University
Joost C. M. Meijers
Joost C. M. Meijers University of Amsterdam
Frits R. Rosendaal
Frits R. Rosendaal Leiden University Medical Center
Stephen H. Caldwell
Stephen H. Caldwell University of Virginia
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Nigel Mackman
Nigel Mackman University of North Carolina at Chapel Hill
James F. Markmann
James F. Markmann Harvard University
Thomas Reiberger
Thomas Reiberger Medical University of Vienna
Peter J. Lenting
Peter J. Lenting University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare careers beyond studying Medicine in the USA? There are a variety of online degree programs that offer flexible pathways into the medical field. Many students begin their journey with a nursing degree online, which can lead to roles such as registered nurse or clinical administrator. These programs are designed for both newcomers and those upgrading their credentials.

For individuals seeking advanced practice roles, affordable np programs offer specialized education to become a Nurse Practitioner, opening doors to higher earning potential and increased responsibilities in patient care.

If you are interested in the administrative side of healthcare, obtaining a medical coding certification can lead to stable employment in hospitals, clinics, and insurers, with the flexibility to work remotely.

For those aiming for leadership, research, or academic positions, online nursing doctoral programs provide the highest level of nursing education and open pathways to teach or direct clinical programs.

Best Scientists Citing Ton Lisman

Trending Scientists